Mice subsequently treated with intra-tumoral injection of EGFR CAR NK cells displayed a significantly reduced tumor growth and prolonged survival, compared to mice inoculated with parental NK-92 cells, thus confirming a specific targeting of tumor cells by EGFR-specific NK CAR [132]. The gene discussed is EGFR; the disease is neoplasm.